Prostate Cancer: genetics in practice now and in the future
Abstract Prostate Cancer (PrCa) is one of the most common cancers worldwide and causes a significant healthcare burden. Recent predictions estimate the incidence of new cases of PrCa will double from 1.4 million in 2020 to 2.9 million by 2040. The known risk factors for PrCa are increasing age, fami...
Saved in:
| Main Authors: | Jana McHugh, Elizabeth Bancroft, Zsofia Kote-Jarai, Rosalind Eeles |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Hereditary Cancer in Clinical Practice |
| Online Access: | https://doi.org/10.1186/s13053-025-00310-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
by: Tom Callender, et al.
Published: (2019-12-01) -
Telomere length shows no association with BRCA1 and BRCA2 mutation status.
by: Emma Killick, et al.
Published: (2014-01-01) -
Comprehensive functional annotation of 77 prostate cancer risk loci.
by: Dennis J Hazelett, et al.
Published: (2014-01-01) -
Genetics and genomics in healthcare: the future is now
by: Lamis Yehia, et al.
Published: (2023-01-01) -
Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
by: Jyotsna Batra, et al.
Published: (2011-01-01)